BioNxt Solutions Inc. (CVE:BNXT)

PRESS RELEASE

published on 10/09/2025 at 09:05, 5 months 15 days ago

BioNxt Completes "Fast-Track" US Track One Patent Filing for Sublingual Delivery of Cladribine for the Treatment of Multiple Sclerosis
BioNxt Solutions Inc. completes Track One priority patent filing with USPTO for sublingual thin-film cladribine formulation (BNT23001) targeting MS & other autoimmune diseases. Strategic move to strengthen IP position & advance regulatory approvals

BioNxt Solutions Inc. Multiple Sclerosis Patent Filing Sublingual Thin-Film Cladribine Formulation
BRIEF

published on 10/02/2025 at 09:10, 5 months 22 days ago

BioNxt développe une plateforme d'administration ciblée de médicaments de chimiothérapie

Biopharmaceutique Solutions BioNxt Administration De Médicaments Chimiothérapie Ciblée Avancées De La Recherche
BRIEF

published on 10/02/2025 at 09:10, 5 months 22 days ago

BioNxt Advances Targeted Chemotherapy Drug Delivery Platform

Biopharmaceutical Drug Delivery Research Advancements BioNxt Solutions Targeted Chemotherapy
PRESS RELEASE

published on 10/02/2025 at 09:05, 5 months 22 days ago

BioNxt Reports Update on Targeted Chemotherapy Drug Delivery Platform
BioNxt Solutions Inc. reports significant advancement in targeted chemotherapy delivery platform and upcoming definitive agreement. Proprietary technology aims at 10-fold increase in therapeutic effect while safeguarding healthy cells

BioNxt Solutions Inc. Oncology Treatments Chemotherapy Delivery Platform Targeted Drug Delivery System Therapeutic Effect
BRIEF

published on 09/29/2025 at 09:10, 5 months 25 days ago

BioNxt Advances Cladribine Sublingual Drug Development for Multiple Sclerosis

Drug Development Multiple Sclerosis Cladribine Bioavailability Sublingual
BRIEF

published on 09/29/2025 at 09:10, 5 months 25 days ago

BioNxt fait progresser le développement d'un médicament sublingual à base de cladribine pour le traitement de la sclérose en plaques

Sclérose En Plaques Cladribine Développement De Médicaments Biodisponibilité Sublingual
PRESS RELEASE

published on 09/29/2025 at 09:05, 5 months 25 days ago

BioNxt Reports Sublingual Cladribine Multiple Sclerosis Drug Milestones Including Large-Animal Study for Validation and Dosing Optimization
BioNxt Solutions provides update on Cladribine sublingual thin-film drug reformulation program, targeting treatment of multiple sclerosis with improved bioavailability and patient adherence

Multiple Sclerosis Cladribine Neurological Disorders BioNxt Solutions Drug Delivery Technologies
BRIEF

published on 09/20/2025 at 03:50, 6 months 4 days ago

BioNxt Solutions lève des actions pour régler sa dette

Actions Ordinaires Règlement De La Dette Solutions BioNxt Valeurs Mobilières Canadiennes Accord De Dette
BRIEF

published on 09/20/2025 at 03:50, 6 months 4 days ago

BioNxt Solutions Completes Shares for Debt Settlement

Common Shares Debt Settlement Debt Agreement Canadian Securities BioNxt Solutions
PRESS RELEASE

published on 09/20/2025 at 03:45, 6 months 4 days ago

BioNxt Solutions Announces Closing of Shares for Debt Settlement
BioNxt Solutions Inc. announces successful debt settlement with creditor, issuing common shares and making cash payment. Company focuses on bioscience innovation and drug delivery technologies

Common Shares Debt Settlement BioNxt Solutions Inc. Drug Delivery Technologies Bioscience Innovation

Published on 03/24/2026 at 18:55, 1 hour ago

Norse Gold Announces Closing of Private Placement Financing and Pending Reactivation on the TSX-V
Published on 03/24/2026 at 13:30, 6 hours 25 minutes ago

GGL Resources Corp. Announces Closing of Earn-In Agreement with Nelson Resources Limited on Its Gold Point High-Grade Gold-Silver Project, Nevada
Published on 03/24/2026 at 13:30, 6 hours 25 minutes ago

Innodata Announces Date of Annual Shareholder Meeting
Published on 03/24/2026 at 12:35, 7 hours 20 minutes ago

Silver X Acquires the High-Grade Pampas Gold-Silver Project, Expanding its Precious Metal Asset Base in Peru
Published on 03/24/2026 at 12:33, 7 hours 22 minutes ago

Mako Mining Completes Acquisition of Mt. Hamilton in Nevada

View all ACCESSWIRE

Published on 03/24/2026 at 19:41, 13 minutes ago

ASMALLWORLD Honoured with Regional Virtuoso Award in Continental Europe for “Most Engaged Member” in Recognition of Their Exceptional Contribution
Published on 03/24/2026 at 19:05, 49 minutes ago

WBS Power Advances 3.2 GW Energy Infrastructure for Hyperscale Data Center Campus
Published on 03/24/2026 at 18:39, 1 hour 15 minutes ago

EQS-Adhoc: FORTEC Elektronik Aktiengesellschaft: Adjustment of the earnings forecast for the financial year 2025/2026
Published on 03/24/2026 at 18:00, 1 hour 55 minutes ago

Cham Swiss Properties places bond of CHF 100 million
Published on 03/24/2026 at 17:50, 2 hours 5 minutes ago

Annual General Meeting of Bellevue Group AG – all proposals approved

View all EQS

Published on 03/24/2026 at 18:21, 1 hour 33 minutes ago

Résultats annuels 2025
Published on 03/24/2026 at 18:21, 1 hour 33 minutes ago

2025 Annual results
Published on 03/24/2026 at 18:00, 1 hour 55 minutes ago

i2S : Résultats annuels 2025
Published on 03/24/2026 at 17:46, 2 hours 8 minutes ago

NRJ GROUP - Avis résultats annuels 2025
Published on 03/24/2026 at 17:46, 2 hours 8 minutes ago

NRJ GROUP - Press release annual results 2025

View all LES ECHOS COMFI WIRE

News